Braster S.A. Stock

BRA

PLBRSTR00014

Biotechnology & Medical Research

Market Closed - Warsaw S.E. 11:55:52 2025-11-27 EST			5-day change	1st Jan Change
0.5800 ^PLN	-.--%		-.--%	-

24-05-29	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
23-11-29	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Braster SA w restrukturyzacji, formerly Braster SA, is a Poland-based company principally engaged in the bio diagnostics and testing. The Company provides research and development on breast cancer. It applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The Company cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.

Employees

Sector

Biotechnology & Medical Research

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

As early as today, start finding the best investment opportunities!

Market Cap	17.04M 4.43M 3.9M 3.69M 3.34M 6.28M 425M 6.31M 44.13M 217M 16.64M 16.28M 698M	P/E 2022	-5.18x	P/E 2023	-3.55x
Enterprise Value	28.34M 7.37M 6.48M 6.13M 5.56M 10.44M 707M 10.5M 73.39M 361M 27.67M 27.07M 1.16B	EV / Sales 2022	15.4x	EV / Sales 2023	88.9x
Free-Float	80.79%	Yield 2022 *	-	Yield 2023	-

24-05-29	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
23-11-29	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-10-03	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-05-24	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-05-02	Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-05-02	Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
22-11-21	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
22-09-27	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	CI
22-05-24	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
22-05-02	Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
21-11-29	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
21-09-30	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	CI
21-09-22	An unknown buyer acquired 21.38% stake in Braster S.A. from Carom Sp. z o.o.	CI

5 years	0.53		1.52
10 years	0.19		28.98

Director	Title	Age	Since
Katarzyna Kilijanczyk BRD	Director/Board Member	-	-
Elzbieta Kozik BRD	Director/Board Member	-	-
Zygfryd Kosidowski BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BRASTER S.A.	-.--%	-.--%	-	-	4.61M
IOVANCE BIOTHERAPEUTICS, INC.	-0.14%	+7.51%	+391.26%	+140.24%	4.98B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-2.04%	+3.05%	+113.30%	+417.30%	4.7B
VERACYTE, INC.	+3.53%	+13.11%	+39.74%	+105.00%	3.65B
CAREDX, INC.	+1.00%	+17.60%	+329.95%	+807.53%	3.29B
BGI GENOMICS CO., LTD.	-1.15%	+12.34%	-8.51%	-16.48%	2.58B
FREENOME, INC.	+3.18%	-8.24%	+48.11%	-	1.72B
SEEGENE, INC.	+0.88%	+1.48%	+37.20%	+60.66%	1.14B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+0.46%	+5.72%	+167.84%	-21.04%	1.13B
CURIOX BIOSYSTEMS CO., LTD	+1.41%	+9.71%	-20.03%	+128.90%	629M
Average	+0.65%	+6.45%	+122.09%	+202.76%	2.38B
Weighted average by Cap.	+0.39%	+7.86%	+167.64%	+261.73%

Braster S.A. Stock

Stocks

BRA

PLBRSTR00014

Biotechnology & Medical Research

Valuation: Braster S.A.

Chart: Braster S.A.

Latest news: Braster S.A.

Price Extremes

Managers and Directors: Braster S.A.

Bio Diagnostics & Testing

Financials

Company Profile

	2022	2023
Net sales	2.24M 582K 512K 484K 439K 825K 55.91M 830K 5.8M 28.53M 2.19M 2.14M 91.68M	319K 82.95K 72.95K 68.99K 62.57K 118K 7.96M 118K 826K 4.06M 311K 305K 13.06M
Net income	-3.87M -1.01M -885K -837K -759K -1.43M -96.65M -1.43M -10.03M -49.32M -3.78M -3.7M -158M	-4.75M -1.23M -1.09M -1.03M -931K -1.75M -119M -1.76M -12.29M -60.47M -4.64M -4.53M -194M
Net Debt	12.42M 3.23M 2.84M 2.69M 2.44M 4.57M 310M 4.6M 32.15M 158M 12.12M 11.86M 508M	11.3M 2.94M 2.58M 2.44M 2.22M 4.16M 282M 4.19M 29.26M 144M 11.03M 10.79M 463M